Company aims to ramp up portfolio as key drugs—that were actually formulated to treat diabetes—go off patent
Company aims to ramp up portfolio as key drugs—that were actually formulated to treat diabetes—go off patent Company aims to ramp up portfolio as key drugs—that were actually formulated to treat diabetes—go off patent Moneycontrol Latest News Read More
